S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
The Market Crash Shield is A.I. (Ad)pixel
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
The Market Crash Shield is A.I. (Ad)pixel
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
The Market Crash Shield is A.I. (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
The Market Crash Shield is A.I. (Ad)pixel
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
The Market Crash Shield is A.I. (Ad)pixel
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
The Market Crash Shield is A.I. (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
The Market Crash Shield is A.I. (Ad)pixel
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
The Market Crash Shield is A.I. (Ad)pixel
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
The Market Crash Shield is A.I. (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
S&P 500   4,109.31
DOW   33,274.15
QQQ   320.93
MarketBeat Week in Review – 3/27 - 3/31
The Market Crash Shield is A.I. (Ad)pixel
UK travelers face hours-long waits for ferries to France
Credit Suisse takeover hits heart of Swiss banking, identity
The Market Crash Shield is A.I. (Ad)pixel
Small areas reopen near Fukushima nuclear plant, few return
'War of the states': EV, chip makers lavished with subsidies
The Market Crash Shield is A.I. (Ad)pixel
Gas prices increase in NJ, around nation amid higher demand
Lanterns and crescents: more retailers court Ramadan buyers
NASDAQ:NVCR

NovoCure - NVCR Insider Trading & Ownership

$60.14
+1.90 (+3.26%)
(As of 03/31/2023 12:00 AM ET)
Add
Compare
Today's Range
$58.34
$60.97
50-Day Range
$56.44
$95.09
52-Week Range
$56.06
$120.03
Volume
577,188 shs
Average Volume
764,206 shs
Market Capitalization
$6.34 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$87.33

NovoCure (NASDAQ:NVCR) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
6.22%
Number Of
Insiders Buying
(Last 12 Months)
0
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$28.17 M

NVCR Insider Buying and Selling by Quarter

Get NVCR Insider Trade Alerts

Want to know when executives and insiders are buying or selling NovoCure stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

NovoCure Insider Trades History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
3/3/2023Frank X LeonardInsiderSell2,059$77.64$159,860.7667,893  
3/1/2023Ashley CordovaCFOSell2,198$76.36$167,839.2896,062  
3/1/2023Frank X LeonardInsiderSell1,684$76.36$128,590.2463,095  
3/1/2023Wilhelmus Cm GroenhuysenCOOSell2,164$76.36$165,243.04184,615  
1/5/2023Asaf DanzigerCEOSell212,500$108.74$23,107,250.0013,583  
1/5/2023Uri WeinbergInsiderSell8,143$116.14$945,728.0243,286  
10/13/2022Frank X LeonardInsiderSell6,754$76.01$513,371.5443,626  
10/6/2022Frank X LeonardInsiderSell6,754$84.37$569,834.9850,380  
9/29/2022Frank X LeonardInsiderSell6,754$77.35$522,421.9057,134  
9/22/2022Frank X LeonardInsiderSell6,754$77.00$520,058.0063,888  
9/15/2022Frank X LeonardInsiderSell12,271$88.52$1,086,228.9270,642  
9/9/2022Frank X LeonardInsiderSell1,863$88.00$163,944.0084,150  
8/2/2022Ely BenaimInsiderSell437$69.66$30,441.4234,631  
8/2/2022William F DoyleChairmanSell837$69.66$58,305.42551,176  
6/10/2022Jeryl L HillemanDirectorSell407$69.61$28,331.272,537  
(Data available from 1/1/2013 forward)












NVCR Insider Trading Activity - Frequently Asked Questions

What percentage of NovoCure stock is owned by insiders?

6.22% of NovoCure stock is owned by insiders. Learn more on NVCR's insider holdings.

Which NovoCure insiders have been buying company stock?

The following insider purchased NVCR shares in the last 24 months: Asaf Danziger ($509,536.56).

How much insider buying is happening at NovoCure?

Insiders have purchased a total of 4,974 NVCR shares in the last 24 months for a total of $509,536.56 bought.

Which NovoCure insiders have been selling company stock?

The following insiders have sold NVCR shares in the last 24 months: Asaf Danziger ($42,343,268.82), Ashley Cordova ($4,173,486.68), Ely Benaim ($2,119,820.51), Frank X Leonard ($3,733,595.34), Gabriel Leung ($1,780,800.00), Jeryl L Hilleman ($28,331.27), Martin J Madden ($5,206.42), Pritesh Shah ($6,254,856.84), Todd Christopher Longsworth ($245,466.90), Uri Weinberg ($945,728.02), Wilhelmus Cm Groenhuysen ($492,089.47), and William F Doyle ($19,182,743.92).

How much insider selling is happening at NovoCure?

Insiders have sold a total of 561,306 NovoCure shares in the last 24 months for a total of $81,380,038.39 sold.

This page (NASDAQ:NVCR) was last updated on 4/2/2023 by MarketBeat.com Staff